Evidence map›Paper›PMID 30658589›Full record

ArticleBMC infectious diseases2019

Unusual manifestations of visceral leishmaniasis in children: a case series and its spatial dispersion in the western region of São Paulo state, Brazil.

Luiz Euribel Prestes-Carneiro, Patricia Rodrigues Naufal Spir, Mateus Fontanesi, Karen Gabriella Pereira Garcia, Francisco Assis da Silva, Edilson Ferreira Flores, Dewton de Moraes Vasconcelos

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Unusual Observations in Leishmaniasis-An Overview.Pathogens (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. How I Approach Leishmaniasis: Diagnosis and Treatment in the United States.Journal of the Pediatric Infectious Diseases Society · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Luiz Euribel Prestes-CarneiroInfectious Diseases and Immunology Department, Oeste Paulista University, Presidente Prudente, São Paulo, Brazil. luiz@unoeste.br.ORCID http://orcid.org/0000-0002-4577-1525
Patricia Rodrigues Naufal SpirPediatrics Department, Oeste Paulista University, Presidente Prudente, São Paulo, Brazil.
Mateus FontanesiImunodeficiencies Outpatient Clinic, Pediatrics Outpatient Clinic, Regional Hospital of Presidente Prudente, Presidente Prudente, São Paulo, Brazil.
Karen Gabriella Pereira GarciaImunodeficiencies Outpatient Clinic, Pediatrics Outpatient Clinic, Regional Hospital of Presidente Prudente, Presidente Prudente, São Paulo, Brazil.
Francisco Assis da SilvaInfectious Diseases and Immunology Department, Oeste Paulista University, Presidente Prudente, São Paulo, Brazil.
Edilson Ferreira FloresStatistics Department, Paulista State University, Presidente Prudente, São Paulo, Brazil.
Dewton de Moraes VasconcelosLaboratory of Medical Investigation Unit 56, Hospital das Clınicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Universidade do Oeste Paulista · BRHospital Regional de Presidente Prudente · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversidade Paulista · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVisceral leishmaniasis (VL) is becoming endemic in São Paulo state, in the southeastern region of Brazil. Unusual manifestations with non-specific signs and symptoms may make diagnosis difficult and delay treatment, increasing the risk of severity and death, particularly in new endemic areas. There are few studies on patients with these characteristics in Brazil. We describe a case series of unusual manifestations of VL in children and its spatial dispersion in the western region of São Paulo state. CASES PRESENTATION: From 2009 to 2014, five clinical cases involving children treated in the Regional Hospital of Presidente Prudente (RH) were selected. Two patients had multiple relapses requiring liposomal amphotericin B; one patient had VL-cytomegalovirus-dengue co-infection and liver injury; one patient was diagnosed with X-linked agammaglobulinemia, a primary immunodeficiency; and one patient was diagnosed with VL-human immunodeficiency virus/acquired immunodeficiency syndrome (VL-HIV/AIDS) co-infection. Primary or secondary immunodeficiencies were found in four children, and associated viral infections were found in three children. Three patients were referred from other hospitals to RH. With regard to the geographic spread of VL, more cases were found in the northern area, in the epicenter of the infection where the first cases were registered, flowing south; a spatial-temporal occurrence was found.

conclusionsPrimary and secondary immunodeficiencies and viral co-infectious should be considered among unusual manifestations of VL, especially in those with multiple relapses. Spatial-temporal occurrence was found. Thus, integrated actions and effective monitoring of the disease are needed to complement curative practices to stem the tide of the epidemic.

Indexed as

Acquired Immunodeficiency SyndromeAgammaglobulinemiaAmphotericin BAnimalsAntiprotozoal AgentsBrazilChildChild, PreschoolCoinfectionCytomegalovirus InfectionsDogsFemaleGenetic Diseases, X-LinkedHumansImmunologic Deficiency SyndromesInfantAmphotericin BAntiprotozoal Agentsliposomal amphotericin BChildrenUnusual manifestations, spatial dispersionVisceral leishmaniasis

Identifiers

PMID30658589
PMCPMC6339277
OpenAlexW2940595508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.